Risk factors for major bleeding in patients with non-valvular atrial fibrillation and CKD G3-G5D on oral anticoagulants

被引：0
|
作者：
Welander, Frida [1 ]
Renlund, Henrik [2 ]
Sjalander, Anders [3 ]
机构：
[1] Umea Univ, Dept Publ Hlth & Clin Med, Dept Res & Dev Sundsvall, Umea, Sweden
[2] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.066
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
430
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls
    Shanah, Layla
    Kabashneh, Sohaip
    Alkassis, Samer
    Ali, Hammad
    Mir, Tanveer
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [32] Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation
    Thomsen, T. Alvaro
    Guadalupe, J. Mesa
    Huerta, C.
    de Burgos, A.
    Soriano, L. Cea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [33] Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
    Halperin, Jonathan L.
    Dorian, Paul
    CURRENT CARDIOLOGY REVIEWS, 2014, 10 (04) : 297 - 302
  • [34] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05): : 364 - 364
  • [35] Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
    Hwang, Ki Won
    Choi, Jin Hee
    Lee, Soo Yong
    Lee, Sang Hyun
    Chon, Min Ku
    Lee, Jungkuk
    Kim, Hasung
    Kim, Yong-Giun
    Choi, Hyung Oh
    Kim, Jeong Su
    Park, Yong-Hyun
    Kim, June Hong
    Chun, Kook Jin
    Nam, Gi-Byoung
    Choi, Kee-Joon
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [36] Effect of new oral anticoagulants on platelet indices in non-valvular atrial fibrillation patients
    Duzen, Irfan Veysel
    Oguz, Elif
    Cekici, Yusuf
    Yavuz, Fethi
    Vuruskan, Ertan
    Sincer, Isa
    Poyraz, Fatih
    Alici, Hayri
    Yuksek, Umit
    Demirtas, Abdullah Orhan
    Sucu, Murat
    HERZ, 2021, 46 (01) : 76 - 81
  • [37] Inappropriate dose of direct oral anticoagulants therapy in patients with non-valvular atrial fibrillation
    Ito, M.
    Kaikita, K.
    Sueta, D.
    Ishii, M.
    Oimatsu, Y.
    Mitsuse, T.
    Arima, Y.
    Iwashita, S.
    Takahashi, A.
    Kanazawa, H.
    Kaneko, S.
    Kanemaru, Y.
    Kiyama, T.
    Yamabe, H.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 485 - 486
  • [38] Dosing of Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation and Renal Dysfunction
    Rymer, Jennifer A.
    Webb, Laura E.
    Wang, Tracy Y.
    CIRCULATION, 2021, 144
  • [39] Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy
    Lip, Gregory Y. H.
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Klem, Christian
    Rosenblatt, Lisa
    Mardekian, Jack
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 405 - 414
  • [40] Renal outcomes in Asian patients receiving oral anticoagulants for non-valvular atrial fibrillation
    Shahzada, Tayyab Salim
    Guo, Cosmos L.
    Lee, Alex P. W.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (01) : 24 - 32
12345